KaloBios Seeks Speedy Approval To Buy Chagas Drug Rights
By Vince Sullivan ( February 23, 2016, 7:42 PM EST) -- Bankrupt biopharmaceutical company KaloBios filed a motion Tuesday in Delaware court seeking rapid approval of a bid to buy the rights to a treatment for Chagas disease in an effort to create a new revenue stream potentially worth hundreds of millions of dollars for the company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.